-
Pneumovax 23 2021 report
Pneumovax 23 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 27 Pages The 5 Key Questions Addressed by this...
-
Prevnar 13 2021 report
Prevnar 13 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 26 Pages The 5 Key Questions Addressed by this...
-
Prevnar 20 2021 report
Prevnar 20 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 24 Pages The 5 Key Questions Addressed by this...
-
Vaxneuvance 2021 report
Vaxneuvance 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 24 Pages The 5 Key Questions Addressed by this Report:...
-
Pradaxa 2020 report
Pradaxa 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 26 Pages The 5 Key Questions Addressed by this Report:...
-
Prolastin-C 2020 report
Prolastin-C 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 26 Pages The 5 Key Questions Addressed by this Report:...
-
Pneumovax 23 2019 report
Pneumovax 23 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 22 Pages The 5 Key Questions Addressed by this...
-
Prevnar 13 2019 report
Prevnar 13 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this...
-
Pneumovax 23 2018 report
Pneumovax 23 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 22 Pages The 5 Key Questions Addressed by this...
-
Prevnar 13 2018 report
Prevnar 13 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this...
-
Pneumovax 23 2017 report
Pneumovax 23 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this...
-
Prevnar 13 2017 report
Prevnar 13 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this...